Clinical Trial Update: Quality of Life and Treatment Satisfaction in β-Thalassemia Patients Receiving Deferasirox

View source ↗

Summary

An update on a clinical trial evaluating quality of life and treatment satisfaction in beta-thalassemia patients treated with deferasirox.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• Exjade (deferasirox)

Snippet

Sponsor: Assiut University | Conditions: β-thalassemia | Status: UNKNOWN